Intravaginal Culture (IVC)

Making fertility care more accessible across Southeast Asia

Bringing clinically proven, cost‑effective fertility treatment to the millions in Southeast Asia who are currently priced out.

Get in touch → How it works ↗
Market opportunity
$16B
APAC fertility market by 2033
70%
of patients priced out of IVF
3M+
IVF cycles needed yearly
<1 in 5
can currently access treatment
Sources: BDA Partners, SART, WHO
01 The challenge

Rising demand, limited access

Across Southeast Asia, fertility demand is rising while access remains limited. Most couples who need treatment will never reach an IVF lab — high costs and scarce infrastructure keep care out of reach for millions.

Explore the challenge →
02 Our solution

The body as a natural incubator

EVEA intravaginal culture uses the woman's own body as a natural incubator environment. It maintains the clinical standard of care while dramatically simplifying clinic setup — making treatment viable at a fraction of the cost.

Discover EVEA →
The EVEA process

Clear process. Published science. Lower cost.

1

Preparation

Eggs and sperm are placed inside the EVEA intravaginal device.

2

Natural incubation

The device is worn for several days, using the woman's body as a natural incubator.

3

Retrieval

The device is removed and embryo development is carefully assessed.

4

Embryo transfer

The best embryo is transferred — same clinical outcomes, far lower cost.

Backed by
Hong Kong Science and Technology Park HKSTP
¹ Ranoux C. et al., Lancet 1988 and subsequent clinical series.
Work with us

Ready to bring IVC to your region?

Whether you're an investor, clinic, or medical professional — we'd love to connect.

Get in touch →